aluates Reports

$ 0.0

Automative

Global LFA-based Cardiac Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-32I9043

Global LFA based Cardiac Market Size Status and Forecast 2022

BUY CHAPTERS

Global LFA-based Cardiac Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-32I9043

Report

June 2025

Pages:131

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Abbott

Danaher

Bio Rad Laboratories

bioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox Laboratories

Wondfo Biotech

Siemens AG

LFA-based Cardiac Market Size

In 2024, the global market size of LFA-based Cardiac was estimated to be worth US$ 4181 million and is forecast to reach approximately US$ 7067 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.

LFA-based Cardiac Market

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

The industry"s leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.

The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of LFA-based Cardiac Market Report

Report Metric	Details
Report Name	LFA-based Cardiac Market
CAGR	7.9%
Segment by Type	Troponin I Troponin T CK-MB Myoglobin Others
Segment by Application	Laboratory Testing Point-of-care Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, Wondfo Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of LFA-based Cardiac in global and regional level.
Chapter 3: Detailed analysis of LFA-based Cardiac company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, LFA-based Cardiac revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Roche share in LFA-based Cardiac Market?

Ans: The industry"s leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.

Who are the main players in the LFA-based Cardiac Market report?

Ans: The main players in the LFA-based Cardiac Market are Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, Wondfo Biotech

What are the Application segmentation covered in the LFA-based Cardiac Market report?

Ans: The Applications covered in the LFA-based Cardiac Market report are Laboratory Testing, Point-of-care Testing

What are the Type segmentation covered in the LFA-based Cardiac Market report?

Ans: The Types covered in the LFA-based Cardiac Market report are Troponin I, Troponin T, CK-MB, Myoglobin, Others

1 Study Coverage

1.1 LFA-based Cardiac Product Introduction

1.2 Market by Type

1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Troponin I

1.2.3 Troponin T

1.2.4 CK-MB

1.2.5 Myoglobin

1.2.6 Others

1.3 Market by Application

1.3.1 Global LFA-based Cardiac Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Laboratory Testing

1.3.3 Point-of-care Testing

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global LFA-based Cardiac Market Size Estimates and Forecasts

2.2 LFA-based Cardiac Market Size by Region: 2024 Versus 2031

2.2.1 Global LFA-based Cardiac Revenue by Region: 2020-2025

2.2.2 Global LFA-based Cardiac Revenue Forecast by Region (2026-2031)

2.2.3 Global LFA-based Cardiac Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global LFA-based Cardiac Revenue by Type (2020-2031)

3.1.2 Global LFA-based Cardiac Revenue Market Share by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global LFA-based Cardiac Revenue by Application (2020-2031)

3.2.2 Global LFA-based Cardiac Revenue Market Share by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Troponin I of LFA-based Cardiac Revenue Market Share by Application

3.3.2 Troponin T of LFA-based Cardiac Revenue Market Share by Application

3.3.3 CK-MB of LFA-based Cardiac Revenue Market Share by Application

3.3.4 Myoglobin of LFA-based Cardiac Revenue Market Share by Application

3.3.5 Others of LFA-based Cardiac Revenue Market Share by Application

4 Global LFA-based Cardiac by Company

4.1 Global LFA-based Cardiac Revenue by Company (2020-2025)

4.2 Global LFA-based Cardiac Revenue Share by Company (2020-2025)

4.3 Competitive Landscape

4.3.1 Key LFA-based Cardiac Companies around the World: Ranking by Revenue

4.3.2 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.3.3 Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.4 Global LFA-based Cardiac Companies Headquarters & Product Type

4.4.1 Global LFA-based Cardiac Companies Headquarters

4.4.2 Date of International Companies Enter into LFA-based Cardiac Market

4.4.3 Global LFA-based Cardiac Companies Product & Service

4.4.4 Troponin I Revenue Market Share of LFA-based Cardiac by Company

4.4.5 Troponin T Revenue Market Share of LFA-based Cardiac by Company

4.4.6 CK-MB Revenue Market Share of LFA-based Cardiac by Company

4.4.7 Myoglobin Revenue Market Share of LFA-based Cardiac by Company

4.4.8 Others Revenue Market Share of LFA-based Cardiac by Company

4.5 Global LFA-based Cardiac Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Roche

5.1.1 Roche Corporation Information

5.1.2 Roche Description, Business Overview

5.1.3 Roche LFA-based Cardiac Products Offered

5.1.4 Roche LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.1.5 Roche LFA-based Cardiac Revenue by Product in 2024

5.1.6 Roche LFA-based Cardiac Revenue by Application in 2024

5.1.7 Roche LFA-based Cardiac Revenue by Geographic Area in 2024

5.1.8 Roche Recent Developments

5.2 Abbott

5.2.1 Abbott Corporation Information

5.2.2 Abbott Description, Business Overview

5.2.3 Abbott LFA-based Cardiac Products Offered

5.2.4 Abbott LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.2.5 Abbott LFA-based Cardiac Revenue by Product in 2024

5.2.6 Abbott LFA-based Cardiac Revenue by Application in 2024

5.2.7 Abbott LFA-based Cardiac Revenue by Geographic Area in 2024

5.2.8 Abbott Recent Developments

5.3 Siemens

5.3.1 Siemens Corporation Information

5.3.2 Siemens Description, Business Overview

5.3.3 Siemens LFA-based Cardiac Products Offered

5.3.4 Siemens LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.3.5 Siemens LFA-based Cardiac Revenue by Product in 2024

5.3.6 Siemens LFA-based Cardiac Revenue by Application in 2024

5.3.7 Siemens LFA-based Cardiac Revenue by Geographic Area in 2024

5.3.8 Siemens Recent Developments

5.4 Danaher

5.4.1 Danaher Corporation Information

5.4.2 Danaher Description, Business Overview

5.4.3 Danaher LFA-based Cardiac Products Offered

5.4.4 Danaher LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.4.5 Danaher LFA-based Cardiac Revenue by Product in 2024

5.4.6 Danaher LFA-based Cardiac Revenue by Application in 2024

5.4.7 Danaher LFA-based Cardiac Revenue by Geographic Area in 2024

5.4.8 Danaher Recent Developments

5.5 Bio-Rad Laboratories

5.5.1 Bio-Rad Laboratories Corporation Information

5.5.2 Bio-Rad Laboratories Description, Business Overview

5.5.3 Bio-Rad Laboratories LFA-based Cardiac Products Offered

5.5.4 Bio-Rad Laboratories LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.5.5 Bio-Rad Laboratories LFA-based Cardiac Revenue by Product in 2024

5.5.6 Bio-Rad Laboratories LFA-based Cardiac Revenue by Application in 2024

5.5.7 Bio-Rad Laboratories LFA-based Cardiac Revenue by Geographic Area in 2024

5.5.8 Bio-Rad Laboratories Recent Developments

5.6 BioMérieux

5.6.1 BioMérieux Corporation Information

5.6.2 BioMérieux Description, Business Overview

5.6.3 BioMérieux LFA-based Cardiac Products Offered

5.6.4 BioMérieux LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.6.5 BioMérieux LFA-based Cardiac Revenue by Product in 2024

5.6.6 BioMérieux LFA-based Cardiac Revenue by Application in 2024

5.6.7 BioMérieux LFA-based Cardiac Revenue by Geographic Area in 2024

5.6.8 BioMérieux Recent Developments

5.7 Thermo Fisher

5.7.1 Thermo Fisher Corporation Information

5.7.2 Thermo Fisher Description, Business Overview

5.7.3 Thermo Fisher LFA-based Cardiac Products Offered

5.7.4 Thermo Fisher LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.7.5 Thermo Fisher LFA-based Cardiac Revenue by Product in 2024

5.7.6 Thermo Fisher LFA-based Cardiac Revenue by Application in 2024

5.7.7 Thermo Fisher LFA-based Cardiac Revenue by Geographic Area in 2024

5.7.8 Thermo Fisher Recent Developments

5.8 Ortho Clinical Diagnostics

5.8.1 Ortho Clinical Diagnostics Corporation Information

5.8.2 Ortho Clinical Diagnostics Description, Business Overview

5.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Products Offered

5.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.8.5 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Product in 2024

5.8.6 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Application in 2024

5.8.7 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Geographic Area in 2024

5.8.8 Ortho Clinical Diagnostics Recent Developments

5.9 LSI Medience Corporation

5.9.1 LSI Medience Corporation Corporation Information

5.9.2 LSI Medience Corporation Description, Business Overview

5.9.3 LSI Medience Corporation LFA-based Cardiac Products Offered

5.9.4 LSI Medience Corporation LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.9.5 LSI Medience Corporation LFA-based Cardiac Revenue by Product in 2024

5.9.6 LSI Medience Corporation LFA-based Cardiac Revenue by Application in 2024

5.9.7 LSI Medience Corporation LFA-based Cardiac Revenue by Geographic Area in 2024

5.9.8 LSI Medience Corporation Recent Developments

5.10 Randox laboratories

5.10.1 Randox laboratories Corporation Information

5.10.2 Randox laboratories Description, Business Overview

5.10.3 Randox laboratories LFA-based Cardiac Products Offered

5.10.4 Randox laboratories LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.10.5 Randox laboratories LFA-based Cardiac Revenue by Product in 2024

5.10.6 Randox laboratories LFA-based Cardiac Revenue by Application in 2024

5.10.7 Randox laboratories LFA-based Cardiac Revenue by Geographic Area in 2024

5.10.8 Randox laboratories Recent Developments

5.11 Wondfo Biotech

5.11.1 Wondfo Biotech Corporation Information

5.11.2 Wondfo Biotech Description, Business Overview

5.11.3 Wondfo Biotech LFA-based Cardiac Products Offered

5.11.4 Wondfo Biotech LFA-based Cardiac Revenue and Gross Margin (2020-2025)

5.11.5 Wondfo Biotech LFA-based Cardiac Revenue by Product in 2024

5.11.6 Wondfo Biotech LFA-based Cardiac Revenue by Application in 2024

5.11.7 Wondfo Biotech LFA-based Cardiac Revenue by Geographic Area in 2024

5.11.8 Wondfo Biotech Recent Developments

6 North America

6.1 North America LFA-based Cardiac Market Size YoY Growth 2020-2031

6.2 North America LFA-based Cardiac Market Facts & Figures by Country (2020-2031)

6.3 North America LFA-based Cardiac Revenue by Type (2020-2025)

6.4 North America LFA-based Cardiac Revenue by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific LFA-based Cardiac Market Size YoY Growth 2020-2031

7.2 Asia-Pacific LFA-based Cardiac Market Facts & Figures by Region (2020-2031)

7.3 Asia-Pacific LFA-based Cardiac Revenue by Type (2020-2025)

7.4 Asia-Pacific LFA-based Cardiac Revenue by Application (2020-2025)

8 Europe

8.1 Europe LFA-based Cardiac Market Size YoY Growth 2020-2031

8.2 Europe LFA-based Cardiac Market Facts & Figures by Country (2020-2031)

8.3 Europe LFA-based Cardiac Revenue by Type (2020-2025)

8.4 Europe LFA-based Cardiac Revenue by Application (2020-2025)

9 Latin America

9.1 Latin America LFA-based Cardiac Market Size YoY Growth 2020-2031

9.2 Latin America LFA-based Cardiac Market Facts & Figures by Country (2020-2031)

9.3 Latin America LFA-based Cardiac Revenue by Type (2020-2025)

9.4 Latin America LFA-based Cardiac Revenue by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America LFA-based Cardiac Market Size YoY Growth 2020-2031

10.2 Middle East and Africa LFA-based Cardiac Market Facts & Figures by Country (2020-2031)

10.3 Middle East and Africa LFA-based Cardiac Revenue by Type (2020-2025)

10.4 Middle East and Africa LFA-based Cardiac Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 LFA-based Cardiac Supply Chain Analysis

11.2 LFA-based Cardiac Key Raw Materials and Upstream Suppliers

11.3 LFA-based Cardiac Clients Analysis

11.4 LFA-based Cardiac Sales Channel and Sales Model Analysis

11.4.1 LFA-based Cardiac Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 LFA-based Cardiac Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 LFA-based Cardiac Distributors

12 LFA-based Cardiac Market Dynamics

12.1 LFA-based Cardiac Industry Trends

12.2 LFA-based Cardiac Market Drivers

12.3 LFA-based Cardiac Market Challenges

12.4 LFA-based Cardiac Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Roche

Abbott

Danaher

Bio Rad Laboratories

bioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox Laboratories

Wondfo Biotech

Siemens AG

List of Tables

Table 1. Global LFA-based Cardiac Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global LFA-based Cardiac Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global LFA-based Cardiac Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global LFA-based Cardiac Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global LFA-based Cardiac Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global LFA-based Cardiac Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)

Table 11. LFA-based Cardiac Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top LFA-based Cardiac Players by Revenue (US$ Million) in 2024

Table 13. Global LFA-based Cardiac Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global LFA-based Cardiac by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2024)

Table 15. Global LFA-based Cardiac Companies Headquarters

Table 16. Date of International Companies Enter into LFA-based Cardiac Market

Table 17. Global LFA-based Cardiac Companies Product & Service

Table 18. Global LFA-based Cardiac Mergers & Acquisitions, Expansion Plans

Table 19. Roche Corporation Information

Table 20. Roche Description and Business Overview

Table 21. Roche LFA-based Cardiac Product

Table 22. Roche LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Roche Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 24. Roche Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 25. Roche Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 26. Roche Recent Developments

Table 27. Abbott Corporation Information

Table 28. Abbott Description and Business Overview

Table 29. Abbott LFA-based Cardiac Product

Table 30. Abbott LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Abbott Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 32. Abbott Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 33. Abbott Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 34. Abbott Recent Developments

Table 35. Siemens Corporation Information

Table 36. Siemens Description and Business Overview

Table 37. Siemens LFA-based Cardiac Product

Table 38. Siemens LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Siemens Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 40. Siemens Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 41. Siemens Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 42. Siemens Recent Developments

Table 43. Danaher Corporation Information

Table 44. Danaher Description and Business Overview

Table 45. Danaher LFA-based Cardiac Product

Table 46. Danaher LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Danaher Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 48. Danaher Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 49. Danaher Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 50. Danaher Recent Developments

Table 51. Bio-Rad Laboratories Corporation Information

Table 52. Bio-Rad Laboratories Description and Business Overview

Table 53. Bio-Rad Laboratories LFA-based Cardiac Product

Table 54. Bio-Rad Laboratories LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 56. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 57. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 58. Bio-Rad Laboratories Recent Developments

Table 59. BioMérieux Corporation Information

Table 60. BioMérieux Description and Business Overview

Table 61. BioMérieux LFA-based Cardiac Product

Table 62. BioMérieux LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. BioMérieux Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 64. BioMérieux Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 65. BioMérieux Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 66. BioMérieux Recent Developments

Table 67. Thermo Fisher Corporation Information

Table 68. Thermo Fisher Description and Business Overview

Table 69. Thermo Fisher LFA-based Cardiac Product

Table 70. Thermo Fisher LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 72. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 73. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 74. Thermo Fisher Recent Developments

Table 75. Ortho Clinical Diagnostics Corporation Information

Table 76. Ortho Clinical Diagnostics Description and Business Overview

Table 77. Ortho Clinical Diagnostics LFA-based Cardiac Product

Table 78. Ortho Clinical Diagnostics LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 80. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 81. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 82. Ortho Clinical Diagnostics Recent Developments

Table 83. LSI Medience Corporation Corporation Information

Table 84. LSI Medience Corporation Description and Business Overview

Table 85. LSI Medience Corporation LFA-based Cardiac Product

Table 86. LSI Medience Corporation LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 88. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 89. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 90. LSI Medience Corporation Recent Developments

Table 91. Randox laboratories Corporation Information

Table 92. Randox laboratories Description and Business Overview

Table 93. Randox laboratories LFA-based Cardiac Product

Table 94. Randox laboratories LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Randox laboratories Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 96. Randox laboratories Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 97. Randox laboratories Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 98. Randox laboratories Recent Developments

Table 99. Wondfo Biotech Corporation Information

Table 100. Wondfo Biotech Description and Business Overview

Table 101. Wondfo Biotech LFA-based Cardiac Product

Table 102. Wondfo Biotech LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Product in 2024

Table 104. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Application in 2024

Table 105. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024

Table 106. Wondfo Biotech Recent Developments

Table 107. North America LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)

Table 108. North America LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)

Table 109. North America LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)

Table 110. North America LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)

Table 111. Asia-Pacific LFA-based Cardiac Revenue by Region (2020-2025) & (US$ Million)

Table 112. Asia-Pacific LFA-based Cardiac Revenue by Region (2026-2031) & (US$ Million)

Table 113. Asia-Pacific LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)

Table 114. Asia-Pacific LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)

Table 115. Europe LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)

Table 116. Europe LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)

Table 117. Europe LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)

Table 118. Europe LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)

Table 119. Latin America LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)

Table 120. Latin America LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)

Table 121. Latin America LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)

Table 122. Latin America LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)

Table 123. Middle East and Africa LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)

Table 124. Middle East and Africa LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)

Table 125. Middle East and Africa LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)

Table 126. Middle East and Africa LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)

Table 127. LFA-based Cardiac Key Raw Materials, Industry Status and Trend

Table 128. LFA-based Cardiac Key Raw Materials and Upstream Suppliers

Table 129. LFA-based Cardiac Clients Status and Trend

Table 130. LFA-based Cardiac Typical Clients

Table 131. LFA-based Cardiac Distributors

Table 132. LFA-based Cardiac Market Trends

Table 133. LFA-based Cardiac Market Drivers

Table 134. LFA-based Cardiac Market Challenges

Table 135. LFA-based Cardiac Market Restraints

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. LFA-based Cardiac Product Picture

Figure 2. Global LFA-based Cardiac Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global LFA-based Cardiac Revenue Market Share by Type in 2024 & 2031

Figure 4. Troponin I Product Picture

Figure 5. Troponin T Product Picture

Figure 6. CK-MB Product Picture

Figure 7. Myoglobin Product Picture

Figure 8. Others Product Picture

Figure 9. Global LFA-based Cardiac Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 10. Global LFA-based Cardiac Revenue Market Share by Application in 2024 & 2031

Figure 11. Laboratory Testing

Figure 12. Point-of-care Testing

Figure 13. LFA-based Cardiac Report Years Considered

Figure 14. Global LFA-based Cardiac Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global LFA-based Cardiac Market Size (2020-2031) & (US$ Million)

Figure 16. Global LFA-based Cardiac Market Size Market Share by Region: 2024 Versus 2031

Figure 17. Global LFA-based Cardiac Revenue Market Share by Region (2020-2031)

Figure 18. Global LFA-based Cardiac Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Global LFA-based Cardiac Revenue Market Share Forecast by Application (2020-2031)

Figure 20. Troponin I of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031

Figure 21. Troponin T of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031

Figure 22. CK-MB of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031

Figure 23. Myoglobin of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031

Figure 24. Others of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031

Figure 25. LFA-based Cardiac Revenue Share by Company (2024)

Figure 26. LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Troponin I Revenue Proportion by Company in 2024

Figure 28. Troponin T Revenue Proportion by Company in 2024

Figure 29. CK-MB Revenue Proportion by Company in 2024

Figure 30. Myoglobin Revenue Proportion by Company in 2024

Figure 31. Others Revenue Proportion by Company in 2024

Figure 32. North America LFA-based Cardiac Revenue 2020-2031 (US$ Million)

Figure 33. North America LFA-based Cardiac Revenue Market Share by Type (2020-2025)

Figure 34. North America LFA-based Cardiac Revenue Market Share by Application (2020-2025)

Figure 35. Asia-Pacific LFA-based Cardiac Revenue 2020-2031 (US$ Million)

Figure 36. Asia-Pacific LFA-based Cardiac Revenue Market Share by Region (2020-2031)

Figure 37. Asia-Pacific LFA-based Cardiac Revenue Market Share by Type (2020-2025)

Figure 38. Asia-Pacific LFA-based Cardiac Revenue Market Share by Application (2020-2025)

Figure 39. Europe LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Europe LFA-based Cardiac Revenue Market Share by Country (2020-2031)

Figure 41. Europe LFA-based Cardiac Revenue Market Share by Type (2020-2025)

Figure 42. Europe LFA-based Cardiac Revenue Market Share by Application (2020-2025)

Figure 43. Latin America LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)

Figure 44. Latin America LFA-based Cardiac Revenue Market Share by Country (2020-2031)

Figure 45. Latin America LFA-based Cardiac Revenue Market Share by Type (2020-2025)

Figure 46. Latin America LFA-based Cardiac Revenue Market Share by Application (2020-2025)

Figure 47. Middle East and Africa LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Middle East and Africa LFA-based Cardiac Revenue Market Share by Country (2020-2031)

Figure 49. Middle East and Africa LFA-based Cardiac Revenue Market Share by Type (2020-2025)

Figure 50. Middle East and Africa LFA-based Cardiac Revenue Market Share by Application (2020-2025)

Figure 51. LFA-based Cardiac Supply Chain (Upstream and Downstream Market)

Figure 52. Global Production Market Share of LFA-based Cardiac Raw Materials by Region in 2024

Figure 53. LFA-based Cardiac Distribution Channels

Figure 54. Global LFA-based Cardiac Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 55. Global LFA-based Cardiac Percentage 2020-2031: Online Sales VS Offline Sales

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Medical Lateral Flow Assay LFA Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

LFA based Rapid Testing Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lateral Flow Test and Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Food Lateral Flow Assay LFA Testing Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Cardiac Reader Systems Market Research Report 2024

Global Cardiac Marker Analyzer Market Research Report 2025

Global Clinical Cardiac Marker Analyzer Market Research Report 2024

Cardiac Markers Testing Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lateral Flow Assay LFA Components Market Research Report 2024

Global POC Cardiac Marker Analyzer Market Research Report 2024

Cardiac Marker POC Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lateral Flow Assay Reader Market Research Report 2024

Global Lateral Flow Assay Cassettes Market Research Report 2024

Global Lateral Flow Immunoassay Membrane Market Research Report 2024

Global ST2 Biomarker Market Research Report 2024

Global Handheld Lateral Flow Readers Market Research Report 2024

Global Diagnostic Biomarker Market Research Report 2024

Lateral Flow Immunoassay Kit for Food Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiac Marker Testing Kits Market Research Report 2025

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions